This content is only available within our institutional offering.
15 Jan 2020
Rude Health - finnCap Life Sciences quarterly sector note
Bioventix Plc (BVXP:LON), 4,475 | Byotrol plc (BYOT:LON), 0.1 | Inspiration Healthcare Group PLC (IHC:LON), 29.0 | Cambridge Nutritional Sciences PLC (CNSL:LON), 4.0 | OptiBiotix Health PLC (OPTI:LON), 18.0 | SDI Group plc (SDI:LON), 56.0 | Synairgen plc (SNG:LON), 6.7 | Tristel Plc (TSTL:LON), 462 | Shield Therapeutics Plc (STX:LON), 1.3 | Evgen Pharma Plc (EVG:LON), 0.8
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Rude Health - finnCap Life Sciences quarterly sector note
Bioventix Plc (BVXP:LON), 4,475 | Byotrol plc (BYOT:LON), 0.1 | Inspiration Healthcare Group PLC (IHC:LON), 29.0 | Cambridge Nutritional Sciences PLC (CNSL:LON), 4.0 | OptiBiotix Health PLC (OPTI:LON), 18.0 | SDI Group plc (SDI:LON), 56.0 | Synairgen plc (SNG:LON), 6.7 | Tristel Plc (TSTL:LON), 462 | Shield Therapeutics Plc (STX:LON), 1.3 | Evgen Pharma Plc (EVG:LON), 0.8
- Published:
15 Jan 2020 -
Author:
Mark Brewer | Cavendish Research -
Pages:
40
The AIM Healthcare index rose by 13% in 2019, marginally outperforming the AIM All Share (+12%). AIM Healthcare was outperformed by the larger cap FT All Share Health and World Health indices (+25% and +17%, respectively), assisted by M&A activity, sustained rate of regulatory approvals and also the defensive nature of the large cap sector, set amidst Brexit uncertainty and earnings downgrades elsewhere in the market. However, there were 17 finnLife 50 stocks that exhibited double-digit percentage increases in the past 12 months, and a further four that exhibited triple-digit percentage increases; namely Silence Therapeutics (+503%), Shield Therapeutics* (+482%), ReNeuron (+184%) and Ergomed (+126%). We remain optimistic for the sector in 2020, given expected inflection points and superior growth.